{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:57:41Z","timestamp":1792144661953,"version":"4.4.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T00:00:00Z","timestamp":1586822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T00:00:00Z","timestamp":1586822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Bulimia nervosa (BN) shares central features with substance-related and addictive disorders. The metabotropic glutamate receptor subtype 5 (mGlu5) plays an important role in addiction. Based on similarities between binge eating and substance-related and addictive disorders, we investigated mGlu5 <jats:italic>in vivo<\/jats:italic> in 15 female subjects with BN and 15 matched controls. We measured mGlu5 distribution volume ratio (DVR) with positron emission tomography (PET) using [11\u2009C]ABP688. In BN mGlu5 DVR was higher in the anterior cingulate cortex (ACC), subgenual prefrontal cortex, and straight gyrus (p\u2009&lt;\u20090.05). In BN, higher mGlu5 DVR in various brain regions, including ACC, pallidum, putamen, and caudate, positively correlated with \u201cmaturity fears\u201d as assessed using the Eating Disorder Inventory-2 (p\u2009&lt;\u20090.05). In BN and controls, smokers had globally decreased mGlu5 DVR. We present the first evidence for increased mGlu5 DVR in BN. Our findings suggest that pharmacological agents inhibiting mGlu5 might have a therapeutic potential in BN.<\/jats:p>","DOI":"10.1038\/s41598-020-63389-7","type":"journal-article","created":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T10:03:12Z","timestamp":1586858592000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Metabotropic glutamate receptor 5 in bulimia nervosa"],"prefix":"10.1038","volume":"10","author":[{"given":"Yoan","family":"Mihov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4584-3031","authenticated-orcid":false,"given":"Valerie","family":"Treyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Funda","family":"Akkus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Toman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Milos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon M.","family":"Ametamey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anass","family":"Johayem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8311-0138","authenticated-orcid":false,"given":"Gregor","family":"Hasler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,14]]},"reference":[{"key":"63389_CR1","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.tips.2019.02.006","volume":"40","author":"BJ Stansley","year":"2019","unstructured":"Stansley, B. J. & Conn, P. J. Neuropharmacological Insight from Allosteric Modulation of mGlu Receptors. Trends. Pharmacol. Sci. 40, 240\u2013252, https:\/\/doi.org\/10.1016\/j.tips.2019.02.006 (2019).","journal-title":"Trends. Pharmacol. Sci."},{"key":"63389_CR2","doi-asserted-by":"publisher","unstructured":"Piers, T. et al. Translational Concepts of mGluR5 in Synaptic Diseases of the Brain. Front. Pharmacol. 3, https:\/\/doi.org\/10.3389\/fphar.2012.00199 (2012).","DOI":"10.3389\/fphar.2012.00199"},{"key":"63389_CR3","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1038\/npp.2009.30","volume":"34","author":"JE Ayala","year":"2009","unstructured":"Ayala, J. E. et al. mGluR5 Positive Allosteric Modulators Facilitate both Hippocampal LTP and LTD and Enhance Spatial Learning. Neuropsychopharmacology. 34, 2057\u20132071, https:\/\/doi.org\/10.1038\/npp.2009.30 (2009).","journal-title":"Neuropsychopharmacology."},{"key":"63389_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neuropharm.2018.10.013","volume":"144","author":"ME Joffe","year":"2019","unstructured":"Joffe, M. E. et al. Mechanisms underlying prelimbic prefrontal cortex mGlu3\/mGlu5-dependent plasticity and reversal learning deficits following acute stress. Neuropharmacology. 144, 19\u201328, https:\/\/doi.org\/10.1016\/j.neuropharm.2018.10.013 (2019).","journal-title":"Neuropharmacology."},{"key":"63389_CR5","doi-asserted-by":"publisher","first-page":"13028","DOI":"10.1523\/jneurosci.2600-08.2008","volume":"28","author":"LS Wijetunge","year":"2008","unstructured":"Wijetunge, L. S., Till, S. M., Gillingwater, T. H., Ingham, C. A. & Kind, P. C. mGluR5 regulates glutamate-dependent development of the mouse somatosensory cortex. J. Neurosci. 28, 13028\u201313037, https:\/\/doi.org\/10.1523\/jneurosci.2600-08.2008 (2008).","journal-title":"J. Neurosci."},{"key":"63389_CR6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2174\/1874473710902010083","volume":"2","author":"MF Olive","year":"2009","unstructured":"Olive, M. F. Metabotropic glutamate receptor ligands as potential therapeutics for addiction. Curr. Drug. Abuse. Rev. 2, 83\u201398 (2009).","journal-title":"Curr. Drug. Abuse. Rev."},{"key":"63389_CR7","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.euroneuro.2008.05.004","volume":"18","author":"A Bisaga","year":"2008","unstructured":"Bisaga, A., Danysz, W. & Foltin, R. W. Antagonism of glutamatergic NMDA and mGluR5 receptors decreases consumption of food in baboon model of binge-eating disorder. Eur. Neuropsychopharmacol. 18, 794\u2013802, https:\/\/doi.org\/10.1016\/j.euroneuro.2008.05.004 (2008).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"63389_CR8","doi-asserted-by":"publisher","unstructured":"Mihov, Y. & Hasler, G. Negative Allosteric Modulators of Metabotropic Glutamate Receptors Subtype 5 in Addiction: a Therapeutic Window. Int. J. Neuropsychopharmacol. 19, https:\/\/doi.org\/10.1093\/ijnp\/pyw002 (2016).","DOI":"10.1093\/ijnp\/pyw002"},{"key":"63389_CR9","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nrn2515","volume":"10","author":"PW Kalivas","year":"2009","unstructured":"Kalivas, P. W. The glutamate homeostasis hypothesis of addiction. Nat. Rev. Neurosci. 10, 561\u2013572, https:\/\/doi.org\/10.1038\/nrn2515 (2009).","journal-title":"Nat. Rev. Neurosci."},{"key":"63389_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.biopsych.2006.03.053","volume":"61","author":"A Markou","year":"2007","unstructured":"Markou, A. Metabotropic glutamate receptor antagonists: novel therapeutics for nicotine dependence and depression? Biol. Psychiatry. 61, 17\u201322, https:\/\/doi.org\/10.1016\/j.biopsych.2006.03.053 (2007).","journal-title":"Biol. Psychiatry."},{"key":"63389_CR11","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.pharmthera.2013.12.012","volume":"142","author":"L Pomierny-Chamiolo","year":"2014","unstructured":"Pomierny-Chamiolo, L. et al. Metabotropic glutamatergic receptors and their ligands in drug addiction. Pharmacol. Ther. 142, 281\u2013305, https:\/\/doi.org\/10.1016\/j.pharmthera.2013.12.012 (2014).","journal-title":"Pharmacol. Ther."},{"key":"63389_CR12","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.biopsych.2012.08.026","volume":"73","author":"DG Smith","year":"2013","unstructured":"Smith, D. G. & Robbins, T. W. The neurobiological underpinnings of obesity and binge eating: a rationale for adopting the food addiction model. Biol. Psychiatry. 73, 804\u2013810, https:\/\/doi.org\/10.1016\/j.biopsych.2012.08.026 (2013).","journal-title":"Biol. Psychiatry."},{"key":"63389_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-013-0396-x","volume":"15","author":"GK Frank","year":"2013","unstructured":"Frank, G. K. Altered brain reward circuits in eating disorders: chicken or egg? Curr. Psychiatry Rep. 15, 396, https:\/\/doi.org\/10.1007\/s11920-013-0396-x (2013).","journal-title":"Curr. Psychiatry Rep."},{"key":"63389_CR14","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1007\/s00213-014-3461-1","volume":"231","author":"NA Hadad","year":"2014","unstructured":"Hadad, N. A. & Knackstedt, L. A. Addicted to palatable foods: comparing the neurobiology of Bulimia Nervosa to that of drug addiction. Psychopharmacology (Berl). 231, 1897\u20131912, https:\/\/doi.org\/10.1007\/s00213-014-3461-1 (2014).","journal-title":"Psychopharmacology (Berl)."},{"key":"63389_CR15","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic And Statistical Manual Of Mental Disorders: DSM-5. 5th edn, (American Psychiatric Association, 2013).","DOI":"10.1176\/appi.books.9780890425596"},{"key":"63389_CR16","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1073\/pnas.1210984110","volume":"110","author":"F Akkus","year":"2013","unstructured":"Akkus, F. et al. Marked global reduction in mGluR5 receptor binding in smokers and ex-smokers determined by [11C]ABP688 positron emission tomography. Proc. Natl. Acad. Sci. USA 110, 737\u2013742, https:\/\/doi.org\/10.1073\/pnas.1210984110 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"63389_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-017-0066-6","volume":"8","author":"F Akkus","year":"2018","unstructured":"Akkus, F. et al. Metabotropic glutamate receptor 5 binding in male patients with alcohol use disorder. Transl. Psychiatry. 8, 17, https:\/\/doi.org\/10.1038\/s41398-017-0066-6 (2018).","journal-title":"Transl. Psychiatry."},{"key":"63389_CR18","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.biopsych.2015.02.027","volume":"79","author":"F Akkus","year":"2016","unstructured":"Akkus, F. et al. Association of Long-Term Nicotine Abstinence With Normal Metabotropic Glutamate Receptor-5 Binding. Biol. Psychiatry. 79, 474\u2013480, https:\/\/doi.org\/10.1016\/j.biopsych.2015.02.027 (2016).","journal-title":"Biol. Psychiatry."},{"key":"63389_CR19","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/mp.2013.51","volume":"19","author":"LM Hulka","year":"2014","unstructured":"Hulka, L. M. et al. Smoking but not cocaine use is associated with lower cerebral metabotropic glutamate receptor 5 density in humans. Mol. Psychiatry. 19, 625\u2013632, https:\/\/doi.org\/10.1038\/mp.2013.51 (2014).","journal-title":"Mol. Psychiatry."},{"key":"63389_CR20","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.neuroimage.2014.04.061","volume":"98","author":"MS Milella","year":"2014","unstructured":"Milella, M. S. et al. Limbic system mGluR5 availability in cocaine dependent subjects: a high-resolution PET [(11)C]ABP688 study. Neuroimage. 98, 195\u2013202, https:\/\/doi.org\/10.1016\/j.neuroimage.2014.04.061 (2014).","journal-title":"Neuroimage."},{"key":"63389_CR21","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.biopsych.2013.06.026","volume":"75","author":"D Martinez","year":"2014","unstructured":"Martinez, D. et al. Imaging glutamate homeostasis in cocaine addiction with the metabotropic glutamate receptor 5 positron emission tomography radiotracer [(11)C]ABP688 and magnetic resonance spectroscopy. Biol. Psychiatry. 75, 165\u2013171, https:\/\/doi.org\/10.1016\/j.biopsych.2013.06.026 (2014).","journal-title":"Biol. Psychiatry."},{"key":"63389_CR22","doi-asserted-by":"publisher","unstructured":"Ceccarini, J. et al. Recovery of decreased metabotropic glutamate receptor 5 availability in abstinent alcohol-dependent patients. J. Nucl. Med., https:\/\/doi.org\/10.2967\/jnumed.119.228825 (2019).","DOI":"10.2967\/jnumed.119.228825"},{"key":"63389_CR23","doi-asserted-by":"publisher","first-page":"682","DOI":"10.2967\/jnumed.117.199422","volume":"59","author":"G Leurquin-Sterk","year":"2018","unstructured":"Leurquin-Sterk, G. et al. Lower Limbic Metabotropic Glutamate Receptor 5 Availability in Alcohol Dependence. J. Nucl. Med. 59, 682\u2013690, https:\/\/doi.org\/10.2967\/jnumed.117.199422 (2018).","journal-title":"J. Nucl. Med."},{"key":"63389_CR24","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.nucmedbio.2010.04.107","volume":"37","author":"C Burger","year":"2010","unstructured":"Burger, C. et al. Evaluation of a bolus\/infusion protocol for 11C-ABP688, a PET tracer for mGluR5. Nucl. Med. Biol. 37, 845\u2013851, https:\/\/doi.org\/10.1016\/j.nucmedbio.2010.04.107 (2010).","journal-title":"Nucl. Med. Biol."},{"key":"63389_CR25","first-page":"698","volume":"47","author":"SM Ametamey","year":"2006","unstructured":"Ametamey, S. M. et al. Radiosynthesis and preclinical evaluation of 11C-ABP688 as a probe for imaging the metabotropic glutamate receptor subtype 5. J. Nucl. Med. 47, 698\u2013705 (2006).","journal-title":"J. Nucl. Med."},{"key":"63389_CR26","first-page":"247","volume":"48","author":"SM Ametamey","year":"2007","unstructured":"Ametamey, S. M. et al. Human PET studies of metabotropic glutamate receptor subtype 5 with 11C-ABP688. J. Nucl. Med. 48, 247\u2013252 (2007).","journal-title":"J. Nucl. Med."},{"key":"63389_CR27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.schres.2016.11.008","volume":"183","author":"F Akkus","year":"2017","unstructured":"Akkus, F. et al. Metabotropic glutamate receptor 5 neuroimaging in schizophrenia. Schizophr. Res. 183, 95\u2013101, https:\/\/doi.org\/10.1016\/j.schres.2016.11.008 (2017).","journal-title":"Schizophr. Res."},{"key":"63389_CR28","doi-asserted-by":"publisher","unstructured":"Gobin, C. & Schwendt, M. The cognitive cost of reducing relapse to cocaine-seeking with mGlu5 allosteric modulators. Psychopharmacology (Berl)., https:\/\/doi.org\/10.1007\/s00213-019-05351-8 (2019).","DOI":"10.1007\/s00213-019-05351-8"},{"key":"63389_CR29","doi-asserted-by":"publisher","unstructured":"Hernandez, C. M. et al. Age-Related Declines in Prefrontal Cortical Expression of Metabotropic Glutamate Receptors that Support Working Memory. eNeuro. 5, https:\/\/doi.org\/10.1523\/eneuro.0164-18.2018 (2018).","DOI":"10.1523\/eneuro.0164-18.2018"},{"key":"63389_CR30","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ejphar.2010.01.029","volume":"639","author":"MF Olive","year":"2010","unstructured":"Olive, M. F. Cognitive effects of Group I metabotropic glutamate receptor ligands in the context of drug addiction. Eur. J. Pharmacol. 639, 47\u201358, https:\/\/doi.org\/10.1016\/j.ejphar.2010.01.029 (2010).","journal-title":"Eur. J. Pharmacol."},{"key":"63389_CR31","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1177\/0269881117746904","volume":"32","author":"CL Haass-Koffler","year":"2018","unstructured":"Haass-Koffler, C. L. et al. Administration of the metabotropic glutamate receptor subtype 5 allosteric modulator GET 73 with alcohol: A translational study in rats and humans. J. Psychopharmacol. 32, 163\u2013173, https:\/\/doi.org\/10.1177\/0269881117746904 (2018).","journal-title":"J. Psychopharmacol."},{"key":"63389_CR32","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.dib.2017.09.018","volume":"15","author":"CL Haass-Koffler","year":"2017","unstructured":"Haass-Koffler, C. L. et al. Dataset for Phase I randomized clinical trial for safety and tolerability of GET 73 in single and repeated ascending doses including preliminary pharmacokinetic parameters. Data Brief. 15, 407\u2013413, https:\/\/doi.org\/10.1016\/j.dib.2017.09.018 (2017).","journal-title":"Data Brief."},{"key":"63389_CR33","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.celrep.2017.06.023","volume":"20","author":"LT Haas","year":"2017","unstructured":"Haas, L. T. et al. Silent Allosteric Modulation of mGluR5 Maintains Glutamate Signaling while Rescuing Alzheimer\u2019s Mouse Phenotypes. Cell Rep. 20, 76\u201388, https:\/\/doi.org\/10.1016\/j.celrep.2017.06.023 (2017).","journal-title":"Cell Rep."},{"key":"63389_CR34","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1017\/s1461145714000716","volume":"17","author":"F Akkus","year":"2014","unstructured":"Akkus, F. et al. Metabotropic glutamate receptor 5 binding in patients with obsessive-compulsive disorder. Int. J. Neuropsychopharmacol. 17, 1915\u20131922, https:\/\/doi.org\/10.1017\/s1461145714000716 (2014).","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"63389_CR35","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1176\/appi.ajp.2011.09111607","volume":"168","author":"A Deschwanden","year":"2011","unstructured":"Deschwanden, A. et al. Reduced metabotropic glutamate receptor 5 density in major depression determined by [(11)C]ABP688 PET and postmortem study. Am. J. Psychiatry. 168, 727\u2013734, https:\/\/doi.org\/10.1176\/appi.ajp.2011.09111607 (2011).","journal-title":"Am. J. Psychiatry."},{"key":"63389_CR36","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.bpsc.2017.03.019","volume":"2","author":"CG Abdallah","year":"2017","unstructured":"Abdallah, C. G. et al. Metabotropic Glutamate Receptor 5 and Glutamate Involvement in Major Depressive Disorder: A Multimodal Imaging Study. Biol. Psychiatry. Cogn. Neurosci. Neuroimaging. 2, 449\u2013456, https:\/\/doi.org\/10.1016\/j.bpsc.2017.03.019 (2017).","journal-title":"Biol. Psychiatry. Cogn. Neurosci. Neuroimaging."},{"key":"63389_CR37","doi-asserted-by":"publisher","unstructured":"Muller Herde, A. et al. Chronic Nicotine Exposure Alters Metabotropic Glutamate Receptor 5: Longitudinal PET Study and Behavioural Assessment in Rats. Neurotox. Res., https:\/\/doi.org\/10.1007\/s12640-019-00055-5 (2019).","DOI":"10.1007\/s12640-019-00055-5"},{"key":"63389_CR38","doi-asserted-by":"publisher","first-page":"952","DOI":"10.2967\/jnumed.117.202614","volume":"59","author":"B de Laat","year":"2018","unstructured":"de Laat, B. et al. Glutamatergic Biomarkers for Cocaine Addiction: A Longitudinal Study Using MR Spectroscopy and mGluR5 PET in Self-Administering Rats. J. Nucl. Med. 59, 952\u2013959, https:\/\/doi.org\/10.2967\/jnumed.117.202614 (2018).","journal-title":"J. Nucl. Med."},{"key":"63389_CR39","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1111\/adb.12635","volume":"24","author":"B de Laat","year":"2019","unstructured":"de Laat, B. et al. Effects of alcohol exposure on the glutamatergic system: a combined longitudinal (18) F-FPEB and (1) H-MRS study in rats. Addict. Biol. 24, 696\u2013706, https:\/\/doi.org\/10.1111\/adb.12635 (2019).","journal-title":"Addict. Biol."},{"key":"63389_CR40","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.conb.2015.12.007","volume":"37","author":"N Kolling","year":"2016","unstructured":"Kolling, N., Behrens, T., Wittmann, M. K. & Rushworth, M. Multiple signals in anterior cingulate cortex. Curr. Opin. Neurobiol. 37, 36\u201343, https:\/\/doi.org\/10.1016\/j.conb.2015.12.007 (2016).","journal-title":"Curr. Opin. Neurobiol."},{"key":"63389_CR41","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1111\/j.1460-9568.2012.08023.x","volume":"35","author":"MP Noonan","year":"2012","unstructured":"Noonan, M. P., Kolling, N., Walton, M. E. & Rushworth, M. F. Re-evaluating the role of the orbitofrontal cortex in reward and reinforcement. Eur. J. Neurosci. 35, 997\u20131010, https:\/\/doi.org\/10.1111\/j.1460-9568.2012.08023.x (2012).","journal-title":"Eur. J. Neurosci."},{"key":"63389_CR42","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.conb.2012.04.011","volume":"22","author":"MF Rushworth","year":"2012","unstructured":"Rushworth, M. F., Kolling, N., Sallet, J. & Mars, R. B. Valuation and decision-making in frontal cortex: one or many serial or parallel systems? Curr. Opin. Neurobiol. 22, 946\u2013955, https:\/\/doi.org\/10.1016\/j.conb.2012.04.011 (2012).","journal-title":"Curr. Opin. Neurobiol."},{"key":"63389_CR43","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.pneurobio.2015.03.002","volume":"127\u2013128","author":"ETT Rolls","year":"2015","unstructured":"Rolls, E. T. T. olfactory, and food reward value processing in the brain. Prog. Neurobiol. 127\u2013128, 64\u201390, https:\/\/doi.org\/10.1016\/j.pneurobio.2015.03.002 (2015).","journal-title":"Prog. Neurobiol."},{"key":"63389_CR44","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1093\/cercor\/13.10.1064","volume":"13","author":"ML Kringelbach","year":"2003","unstructured":"Kringelbach, M. L., O\u2019Doherty, J., Rolls, E. T. & Andrews, C. Activation of the human orbitofrontal cortex to a liquid food stimulus is correlated with its subjective pleasantness. Cereb. Cortex. 13, 1064\u20131071 (2003).","journal-title":"Cereb. Cortex."},{"key":"63389_CR45","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1038\/s41593-017-0008-x","volume":"20","author":"S Suzuki","year":"2017","unstructured":"Suzuki, S., Cross, L. & O\u2019Doherty, J. P. Elucidating the underlying components of food valuation in the human orbitofrontal cortex. Nat. Neurosci. 20, 1780\u20131786, https:\/\/doi.org\/10.1038\/s41593-017-0008-x (2017).","journal-title":"Nat. Neurosci."},{"key":"63389_CR46","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.biopsych.2017.08.025","volume":"84","author":"I Esterlis","year":"2018","unstructured":"Esterlis, I., Holmes, S. E., Sharma, P., Krystal, J. H. & DeLorenzo, C. Metabotropic Glutamatergic Receptor 5 and Stress Disorders: Knowledge Gained From Receptor Imaging Studies. Biol. Psychiatry. 84, 95\u2013105, https:\/\/doi.org\/10.1016\/j.biopsych.2017.08.025 (2018).","journal-title":"Biol. Psychiatry."},{"key":"63389_CR47","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.neuropharm.2014.04.016","volume":"84","author":"G Nowak","year":"2014","unstructured":"Nowak, G. et al. Prolonged administration of antidepressant drugs leads to increased binding of [(3)H]MPEP to mGlu5 receptors. Neuropharmacology. 84, 46\u201351, https:\/\/doi.org\/10.1016\/j.neuropharm.2014.04.016 (2014).","journal-title":"Neuropharmacology."},{"key":"63389_CR48","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/s0028-3908(02)00062-x","volume":"42","author":"M Smialowska","year":"2002","unstructured":"Smialowska, M. et al. Effect of chronic imipramine or electroconvulsive shock on the expression of mGluR1a and mGluR5a immunoreactivity in rat brain hippocampus. Neuropharmacology. 42, 1016\u20131023, https:\/\/doi.org\/10.1016\/s0028-3908(02)00062-x (2002).","journal-title":"Neuropharmacology."},{"key":"63389_CR49","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/mp.2017.58","volume":"23","author":"I Esterlis","year":"2018","unstructured":"Esterlis, I. et al. Ketamine-induced reduction in mGluR5 availability is associated with an antidepressant response: an [(11)C]ABP688 and PET imaging study in depression. Mol. Psychiatry. 23, 824\u2013832, https:\/\/doi.org\/10.1038\/mp.2017.58 (2018).","journal-title":"Mol. Psychiatry."},{"key":"63389_CR50","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/1098-108X(199412)16:4<363::AID-EAT2260160405>3.0.CO;2-#","volume":"16","author":"CG Fairburn","year":"1994","unstructured":"Fairburn, C. G. & Beglin, S. J. Assessment of eating disorders: interview or self-report questionnaire? Int. J. Eat. Disord. 16, 363\u2013370 (1994).","journal-title":"Int. J. Eat. Disord."},{"key":"63389_CR51","doi-asserted-by":"publisher","unstructured":"Hilbert, A., Tuschen-Caffier, B., Karwautz, A., Niederhofer, H. & Munsch, S. Eating Disorder Examination-Questionnaire: Psychometric properties of the German version. Diagnostica. 53, pp, https:\/\/doi.org\/10.1026\/0012-1924.53.3.144 (2007).","DOI":"10.1026\/0012-1924.53.3.144"},{"key":"63389_CR52","first-page":"365","volume":"47","author":"A Thiel","year":"1997","unstructured":"Thiel, A. et al. A German version of the Eating Disorder Inventory EDI-2. Psychother. Psychosom. Med. Psychol. 47, 365\u2013376 (1997).","journal-title":"Psychother. Psychosom. Med. Psychol."},{"key":"63389_CR53","doi-asserted-by":"publisher","unstructured":"Esterlis, I., Holmes, S. E., Sharma, P., Krystal, J. H. & DeLorenzo, C. Metabotropic Glutamatergic Receptor 5 and Stress Disorders: Knowledge Gained From Receptor Imaging Studies. Biol. Psychiatry., https:\/\/doi.org\/10.1016\/j.biopsych.2017.08.025 (2017).","DOI":"10.1016\/j.biopsych.2017.08.025"},{"key":"63389_CR54","doi-asserted-by":"publisher","first-page":"8390","DOI":"10.1073\/pnas.1701749114","volume":"114","author":"SE Holmes","year":"2017","unstructured":"Holmes, S. E. et al. Altered metabotropic glutamate receptor 5 markers in PTSD: In vivo and postmortem evidence. Proc. Natl. Acad. Sci. USA 114, 8390\u20138395, https:\/\/doi.org\/10.1073\/pnas.1701749114 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"63389_CR55","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1038\/npp.2012.41","volume":"37","author":"S Grob","year":"2012","unstructured":"Grob, S. et al. Dopamine-related deficit in reward learning after catecholamine depletion in unmedicated, remitted subjects with bulimia nervosa. Neuropsychopharmacology. 37, 1945\u20131952, https:\/\/doi.org\/10.1038\/npp.2012.41 (2012).","journal-title":"Neuropsychopharmacology."},{"key":"63389_CR56","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.biopsych.2013.09.013","volume":"77","author":"S Grob","year":"2015","unstructured":"Grob, S. et al. Behavioral responses to catecholamine depletion in unmedicated, remitted subjects with bulimia nervosa and healthy subjects. Biol. Psychiatry. 77, 661\u2013667, https:\/\/doi.org\/10.1016\/j.biopsych.2013.09.013 (2015).","journal-title":"Biol. Psychiatry."},{"key":"63389_CR57","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.euroneuro.2017.04.002","volume":"27","author":"SV Mueller","year":"2017","unstructured":"Mueller, S. V., Mihov, Y., Federspiel, A., Wiest, R. & Hasler, G. Neural response to catecholamine depletion in remitted bulimia nervosa: Relation to depression and relapse. Eur. Neuropsychopharmacol. 27, 633\u2013646, https:\/\/doi.org\/10.1016\/j.euroneuro.2017.04.002 (2017).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"63389_CR58","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/npp.2017.277","volume":"43","author":"SV Mueller","year":"2018","unstructured":"Mueller, S. V. et al. Neural Correlates of Impaired Reward-Effort Integration in Remitted Bulimia Nervosa. Neuropsychopharmacology. 43, 868\u2013876, https:\/\/doi.org\/10.1038\/npp.2017.277 (2018).","journal-title":"Neuropsychopharmacology."},{"key":"63389_CR59","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3389\/fnbeh.2016.00044","volume":"10","author":"GK Frank","year":"2016","unstructured":"Frank, G. K. The Perfect Storm - A Bio-Psycho-Social Risk Model for Developing and Maintaining Eating Disorders. Front. Behav. Neurosci. 10, 44, https:\/\/doi.org\/10.3389\/fnbeh.2016.00044 (2016).","journal-title":"Front. Behav. Neurosci."},{"key":"63389_CR60","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s00259-014-2883-7","volume":"42","author":"SM Sephton","year":"2015","unstructured":"Sephton, S. M. et al. Preclinical evaluation and test-retest studies of [(18)F]PSS232, a novel radioligand for targeting metabotropic glutamate receptor 5 (mGlu5). Eur. J. Nucl. Med. Mol. Imaging. 42, 128\u2013137, https:\/\/doi.org\/10.1007\/s00259-014-2883-7 (2015).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging."},{"key":"63389_CR61","doi-asserted-by":"publisher","first-page":"388","DOI":"10.2967\/jnumed.112.107995","volume":"54","author":"DF Wong","year":"2013","unstructured":"Wong, D. F. et al. 18F-FPEB, a PET radiopharmaceutical for quantifying metabotropic glutamate 5 receptors: a first-in-human study of radiochemical safety, biokinetics, and radiation dosimetry. J Nucl Med. 54, 388\u2013396, https:\/\/doi.org\/10.2967\/jnumed.112.107995 (2013).","journal-title":"J Nucl Med."},{"key":"63389_CR62","unstructured":"First, M., Spitzer, R. L., Gibbon, M. L. & Williams, J. Structured Clinical Interview For DSM-IV-TR Axis I Disorders, Research Version, Non-Patient Edition. (2002)."},{"key":"63389_CR63","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1037\/0022-006X.56.6.893","volume":"56","author":"AT Beck","year":"1988","unstructured":"Beck, A. T., Epstein, N., Brown, G. & Steer, R. A. An inventory for measuring clinical anxiety: psychometric properties. J. Consult. Clin. Psychol. 56, 893\u2013897 (1988).","journal-title":"J. Consult. Clin. Psychol."},{"key":"63389_CR64","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","volume":"4","author":"AT Beck","year":"1961","unstructured":"Beck, A. T., Ward, C. H., Mendelson, M., Mock, J. & Erbaugh, J. An inventory for measuring depression. Arch. Gen. Psychiatry. 4, 561\u2013571 (1961).","journal-title":"Arch. Gen. Psychiatry."},{"key":"63389_CR65","unstructured":"Garner, D. M. Eating Disorder Inventory-2: Professional Manual. (Psychological Assessment Resources, 1991)."},{"key":"63389_CR66","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1192\/bjp.174.4.297","volume":"174","author":"P Bollini","year":"1999","unstructured":"Bollini, P., Pampallona, S., Tibaldi, G., Kupelnick, B. & Munizza, C. Effectiveness of antidepressants. Meta-analysis of dose-effect relationships in randomised clinical trials. Br. J. Psychiatry. 174, 297\u2013303 (1999).","journal-title":"Br. J. Psychiatry."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-63389-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-63389-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-63389-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T09:21:24Z","timestamp":1670318484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-63389-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,14]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["63389"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-63389-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,14]]},"assertion":[{"value":"1 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6374"}}